Host-related factors in breast cancer: An underappreciated piece of the puzzle?

Journal of Clinical Oncology

Volumn 26, Issue 20, 2008, Pages 3299-3300

  Goodwin, Pamela J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; INSULIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN; TRASTUZUMAB; INTEGRATION HOST FACTOR;

ALCOHOL CONSUMPTION; BREAST CANCER; CANCER RISK; CARCINOGENESIS; DIET; EDITORIAL; ENVIRONMENTAL EXPOSURE; EXERCISE; HEREDITY; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; OBESITY; PHYSICAL ACTIVITY; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; NOTE; PATHOLOGY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INTEGRATION HOST FACTORS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 49149131180     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.4526     Document Type: Editorial

References (10)

1. Morris SR, Carey LA: Molecular profiling in breast cancer. Rev Endocr Metab Disord 8:185-198, 2007
2. Hortobagyi GN: Trastuzumab in the treatment of breast cancer. N Engl J Med 353:1734-1736, 2005
3. Barnett GC, Shah M, Redman K, et al: Risk factors for the incidence of breast cancer: Do they affect survival from the disease? J Clin Oncol 26:3310-3316, 2008
4. Phillips KA, Milne RL, Friedlander ML, et al: Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol 22:699-705, 2004
5. Goodwin PJ: Energy balance and cancer prognosis: Breast cancer, in McTiernan A (ed): Cancer Prevention and Management Through Exercise and Weight Control. Boca Raton, FL, Taylor and Francis Group, 2006, pp 405-435
6. Goodwin PJ, Ennis M, Pritchard KI, et al: Fasting insulin and outcome in early stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20:42-51, 2002
7. Pasanisi P, Berrino F, De Petris M, et al: Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236-238, 2006
8. Pollak MN, Chapman JW, Shepherd L, et al: Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA 14 adjuvant breast cancer trial. J Clin Oncol 24:9s, 2006 (abstr 524)
9. Chlebowski RT, Aiello E, McTiernan A: Weight loss in breast cancer patient management. J Clin Oncol 20:1128-1143, 2002
10. Mulligan AM, O'Malley FP, Ennis M, et al: Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Res Treat 106:39-47, 2007